Propranolol (Cardiovascular)

Intravenous propranolol is used in monitored medical settings to treat serious heart rhythm problems, including:

• Supraventricular tachycardia (SVT) — rapid rhythms starting in the upper chambers of the heart, including those caused by Wolff-Parkinson-White syndrome or an overactive thyroid
• Atrial flutter or atrial fibrillation — when standard treatments haven't worked or more prolonged rate control is needed
• Ventricular tachycardia — dangerous fast rhythms in the lower chambers, particularly when other options have failed
• Digitalis toxicity-related arrhythmias — life-threatening rhythm problems caused by too much digoxin
• Arrhythmias during anesthesia — fast rhythms triggered by excess adrenaline-like chemicals released during surgery
• Persistent premature ventricular beats — extra heartbeats from the lower chambers that are affecting patient well-being and haven't responded to standard treatment

Propranolol is a nonselective beta-blocker, meaning it blocks both beta-1 receptors (found mainly in the heart) and beta-2 receptors (found in the lungs, blood vessels, and other smooth muscle). Blocking the heart's beta-1 receptors slows the heart rate, reduces the force of contractions, and slows electrical conduction through the AV node — the heart's internal relay station. These combined effects help stop or control abnormal rhythms.

Because propranolol also blocks beta-2 receptors, it can cause the airways and blood vessels to constrict (tighten), which is why it must be used with great caution — or avoided entirely — in people with asthma or other lung conditions. At higher doses, propranolol also has a mild stabilizing effect on the heart's electrical activity similar to some other antiarrhythmic drugs.

Propranolol in this intravenous form is administered only by a healthcare professional in a closely monitored setting, such as a hospital or procedure suite. It is given slowly into a vein, with continuous monitoring of heart rhythm and blood pressure throughout.

• It is given at a controlled, slow rate to minimize the risk of blood pressure dropping too low or the heart stopping.
• A second dose may be given after a short wait if needed, but additional doses are not given sooner than four hours after that.
• Once your heart rhythm is stable, your team will switch you to an oral (by-mouth) propranolol as quickly as possible.

The most common side effects with IV propranolol involve the heart and circulation. These include:

Serious reactions — including cardiac arrest, severe bronchospasm (airway tightening), and dangerously slow heart rate — require immediate medical attention. These are managed by your care team in a monitored setting.

• Heart failure: Propranolol reduces the heart's pumping strength. In patients with active or fragile heart failure, it can make the condition significantly worse.
• Lung disease: People with asthma, chronic bronchitis, or emphysema are at serious risk of bronchospasm (airways squeezing shut). Propranolol is contraindicated in bronchial asthma.
• Diabetes: Propranolol can hide the usual warning signs (like a racing pulse) of low blood sugar — making it harder to catch a dangerous hypoglycemic episode, especially in insulin-dependent patients or children fasting before surgery.
• Thyroid disease: Propranolol can mask the signs of an overactive thyroid. Stopping it abruptly in someone with thyroid disease can trigger thyroid storm — a dangerous, sudden worsening of hyperthyroid symptoms.
• Major surgery: Propranolol blunts the heart's ability to respond to stress during surgery. Your entire surgical team should know you are receiving this medication.

Several drugs and substances can interact with IV propranolol in ways that increase risk:

• Digitalis (digoxin): Both slow the heart; together they can cause extreme bradycardia or heart block.
• Catecholamines (epinephrine, dopamine, isoproterenol): Propranolol blocks their effects on the heart, but epinephrine in particular can still cause uncontrolled high blood pressure when propranolol is on board.
• General anesthetic agents: All inhaled anesthetics suppress heart function to some degree; propranolol adds to that suppression — requiring constant monitoring during surgery.
• Insulin and diabetes medications: Propranolol can make blood sugar harder to manage and hide the typical warning signs of a low blood sugar episode.
• Dobutamine or isoproterenol: These can be used to reverse propranolol's effects in an overdose or emergency, though they must be handled with care.
• Aminophylline: May be useful if propranolol triggers bronchospasm, per overdose guidance.

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

• Bronchial asthma: Propranolol is contraindicated — it can cause a severe, life-threatening airway reaction.
• Cardiogenic shock or severe heart failure: Contraindicated — propranolol can further depress heart function.
• Significant bradycardia or heart block: Contraindicated — propranolol slows conduction further and can cause the heart to stop.
• Known allergy to propranolol: Do not use.
• Diabetes: Tell your team — propranolol can mask low blood sugar and complicate insulin dosing.
• Thyroid disease: Disclose to your team — stopping propranolol abruptly can trigger a dangerous thyroid flare.
• Chronic lung disease (emphysema, bronchitis): Use with extreme caution — propranolol can worsen breathing.
• Children and infants: Associated with hypoglycemia (low blood sugar), especially during fasting periods.
• Renal (kidney) insufficiency: Associated with increased risk of hypoglycemia.
• Upcoming major surgery: All members of the surgical team should be informed.

Too much propranolol can cause dangerously low blood pressure and a very slow heart rate, and it is not significantly removed by dialysis. In an overdose situation, medical staff may use glucagon, dopamine, or isoproterenol to support heart function, and atropine or temporary cardiac pacing to treat a severely slow heart rate. Epinephrine is used with caution because it can cause uncontrolled high blood pressure in this setting.

Propranolol blocks the beta-adrenergic receptors that respond to adrenaline-like signals in the body. In the heart, this slows the rate of both normal and abnormal pacemaker cells, reduces electrical conduction through the AV node, and decreases the force of each heartbeat. These effects work together to control abnormal heart rhythms and slow a dangerously fast heart rate. Because it also blocks beta-2 receptors in the airways and blood vessels, it can cause those muscles to constrict — which is why lung disease is such an important concern.

After IV administration, propranolol distributes rapidly through the body, with an initial distribution half-life of about 5 to 10 minutes, meaning it reaches its target tissues quickly. About 90% of the drug binds to proteins in the blood. It is then processed (eliminated) over 2 to 5.5 hours, which reflects how long the drug's effects last in the body. Because it acts and clears relatively quickly when given intravenously, medical staff can monitor its effects in real time and adjust treatment as needed.

Store at 20° to 25°C (68° to 77°F) . Protect from freezing and excessive heat.